Atherosclerosis Archives - Page 19 of 21

Deferred vs Complete Revascularization in Patients With Diabetes

November 4, 2016

Deferred revascularization in patients with diabetes, especially those with previous myocardial infarction, is associated with poor medium-term outcomes.

CHD

Cardiometabolic Syndrome Increases Risk of Subclinical Atherosclerosis

October 28, 2016

Participants with cardiometabolic syndrome had higher odds ratios of having a positive coronary artery calcification and carotid artery intima-media thickness.

High Sensitivity Cardiac Troponin I in ER

Stroke

High-Sensitivity Cardiac Troponin T Levels Linked to Cerebral Microbleeds

By

Laura Stiles

October 25, 2016

Patients in the highest hs-cTnT tertile were more likely to have cerebral microbleeds and deep or infratentorial cerebral microbleeds, after adjustments.

CHD

CVD Risk Management in Rheumatoid Arthritis: Updated Guidelines

By

Corinna Panlilio Sison, MD

October 10, 2016

The European League Against Rheumatism (EULAR) has released updated guidelines for cardiovascular disease risk assessment in patients with rheumatoid arthritis.

CHD

Current Smoking Linked to Changes in Cardiac Structure and Function

By

Crystal Wong, MD

September 13, 2016

Cumulative cigarette exposure correlated with increased measures of left ventricular mass and worse diastolic function.

ESC Meeting Highlights

Low Diastolic Blood Pressure Associated With Subclinical Myocardial Damage

By

Jason Harris

September 2, 2016

Low diastolic blood pressure may harm the myocardium, which could lead to coronary heart disease.

CHD

Psoriasis Associated With Increased Coronary Artery Calcium

August 29, 2016

Similar to patients with diabetes, patients with psoriasis had low CV risk on the Framingham Risk Score, but high prevalence of CV and cardiometabolic risk factors.

CHD

Statin Limitation Could Benefit Elderly Patients

By

Jason Harris

August 22, 2016

Specificity, or less overtreatment, increased from 15% to 25% for both coronary heart disease and cardiovascular disease

Chronic inflammatory conditions are established risk factors for the development of cardiovascular disease (CVD). Like most patients with rheumatic disease, patients with ankylosing spondylitis (AS) are at greater risk than the general population for CVD, risk factors for CVD, and cardiovascular mortality.[1] Although studies have attempted to quantify the degree of excess risk of CVD and cardiovascular mortality, it is difficult to determine how AS treatments and AS-related lifestyle changes affect the patient’s cardiovascular risk. None of the studies that analyzed the relationship between cardiovascular risk and AS were randomized, controlled clinical trials; available data derive mainly from observational studies. Nevertheless, an accumulation of data from the 1930s to the present conclusively shows that AS contributes to harmful cardiovascular changes.[1] Clinicians need to be familiar with common cardiovascular complications of AS so they can help patients minimize their risk.

CHD

Autoimmune Inflammatory Disorders Associated With CVD Morbidity

August 18, 2016

Patients with ankylosing spondylitis, a chronic inflammatory autoimmune disorder, have an increased of cardiovascular morbidity and mortality.

Dyslipidemia

PCSK9 Inhibitors Not Cost-Effective in ASCVD

August 17, 2016

For PCSK9 inhibitors to be cost-effective at less than $100 000 per quality-adjusted life year, annual drug costs would need to be reduced to $4536 per patient or less.